Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data

BACKGROUND: This study assesses the use of hormonal therapy to treat high-risk localized prostate cancer (HRLPCa) cases diagnosed between 2005 and 2015. METHODS: All N(0-X)M(0) with ≥T(3a,) or PCa cases with poorly differentiated feature (equivalent to Gleason score ≥ 8), diagnosed between 2005 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abera, Semaw Ferede, Bedir, Ahmed, Glowka, André, Vordermark, Dirk, Medenwald, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171996/
https://www.ncbi.nlm.nih.gov/pubmed/35672732
http://dx.doi.org/10.1186/s12885-022-09677-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171996/
https://www.ncbi.nlm.nih.gov/pubmed/35672732
http://dx.doi.org/10.1186/s12885-022-09677-z

Ejemplares similares